hla-mismatched stem cell
Cell therapyexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2004 (NCT02461121)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hla matched stem cell
- hla-mismatched donor peripheral stem cell infusion
- hla mismatched stem cell
- hla-mismatched stem cell
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05095558 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2021 | People's Liberation Army of China |
| NCT04937842 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2021 | Fengtai You'anmen Hospital, People's Liberation Army of China |
| NCT05262465 | N/A | Jul 1, 2020 | People's Liberation Army of China |
| NCT02255162 | Phase 1 | Jan 1, 2015 | Celgene, Harvard University |
| NCT02171117 | Phase 3 | Mar 1, 2014 | People's Liberation Army of China |
| NCT02461121 | Phase 3 | May 1, 2004 | People's Liberation Army of China |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| People's Liberation Army of China | Government | 5 | 5 | 3 | 2004 |
| Celgene | For profit | 1 | 0 | 1 | 2015 |
| Fengtai You'anmen Hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1